Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

39 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prolonged survival of dendritic cell-vaccinated melanoma patients correlates with tumor-specific delayed type IV hypersensitivity response and reduction of tumor growth factor beta-expressing T cells.
López MN, Pereda C, Segal G, Muñoz L, Aguilera R, González FE, Escobar A, Ginesta A, Reyes D, González R, Mendoza-Naranjo A, Larrondo M, Compán A, Ferrada C, Salazar-Onfray F. López MN, et al. Among authors: gonzalez fe, gonzalez r. J Clin Oncol. 2009 Feb 20;27(6):945-52. doi: 10.1200/JCO.2008.18.0794. Epub 2009 Jan 12. J Clin Oncol. 2009. PMID: 19139436 Clinical Trial.
Heat-shock induction of tumor-derived danger signals mediates rapid monocyte differentiation into clinically effective dendritic cells.
Aguilera R, Saffie C, Tittarelli A, González FE, Ramírez M, Reyes D, Pereda C, Hevia D, García T, Salazar L, Ferreira A, Hermoso M, Mendoza-Naranjo A, Ferrada C, Garrido P, López MN, Salazar-Onfray F. Aguilera R, et al. Among authors: gonzalez fe. Clin Cancer Res. 2011 Apr 15;17(8):2474-83. doi: 10.1158/1078-0432.CCR-10-2384. Epub 2011 Feb 3. Clin Cancer Res. 2011. PMID: 21292818 Clinical Trial.
Toll-like receptor 4 gene polymorphism influences dendritic cell in vitro function and clinical outcomes in vaccinated melanoma patients.
Tittarelli A, González FE, Pereda C, Mora G, Muñoz L, Saffie C, García T, Díaz D, Falcón C, Hermoso M, López MN, Salazar-Onfray F. Tittarelli A, et al. Among authors: gonzalez fe. Cancer Immunol Immunother. 2012 Nov;61(11):2067-77. doi: 10.1007/s00262-012-1268-7. Epub 2012 May 3. Cancer Immunol Immunother. 2012. PMID: 22552381 Free PMC article.
Tumor cell lysates as immunogenic sources for cancer vaccine design.
González FE, Gleisner A, Falcón-Beas F, Osorio F, López MN, Salazar-Onfray F. González FE, et al. Hum Vaccin Immunother. 2014;10(11):3261-9. doi: 10.4161/21645515.2014.982996. Hum Vaccin Immunother. 2014. PMID: 25625929 Free PMC article. Review.
Role of Dendritic Cells in the Induction of Lymphocyte Tolerance.
Osorio F, Fuentes C, López MN, Salazar-Onfray F, González FE. Osorio F, et al. Among authors: gonzalez fe. Front Immunol. 2015 Oct 20;6:535. doi: 10.3389/fimmu.2015.00535. eCollection 2015. Front Immunol. 2015. PMID: 26539197 Free PMC article. Review.
Tumor lysate-based vaccines: on the road to immunotherapy for gallbladder cancer.
Rojas-Sepúlveda D, Tittarelli A, Gleisner MA, Ávalos I, Pereda C, Gallegos I, González FE, López MN, Butte JM, Roa JC, Fluxá P, Salazar-Onfray F. Rojas-Sepúlveda D, et al. Among authors: gonzalez fe. Cancer Immunol Immunother. 2018 Dec;67(12):1897-1910. doi: 10.1007/s00262-018-2157-5. Epub 2018 Mar 29. Cancer Immunol Immunother. 2018. PMID: 29600445 Free PMC article. Review.
39 results